Enclave Advisors LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Enclave Advisors LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,227 shares of the healthcare conglomerate’s stock after purchasing an additional 79 shares during the quarter. Enclave Advisors LLC’s holdings in UnitedHealth Group were worth $1,632,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in UNH. Resources Management Corp CT ADV lifted its stake in UnitedHealth Group by 4.2% during the second quarter. Resources Management Corp CT ADV now owns 13,839 shares of the healthcare conglomerate’s stock worth $7,048,000 after purchasing an additional 563 shares during the last quarter. Manchester Global Management UK Ltd lifted its position in UnitedHealth Group by 12.7% in the 2nd quarter. Manchester Global Management UK Ltd now owns 154,918 shares of the healthcare conglomerate’s stock worth $78,894,000 after buying an additional 17,500 shares during the last quarter. Mill Creek Capital Advisors LLC grew its position in UnitedHealth Group by 20.1% during the second quarter. Mill Creek Capital Advisors LLC now owns 1,983 shares of the healthcare conglomerate’s stock valued at $1,010,000 after acquiring an additional 332 shares during the last quarter. Distillate Capital Partners LLC lifted its holdings in shares of UnitedHealth Group by 563,752.2% in the 2nd quarter. Distillate Capital Partners LLC now owns 129,686 shares of the healthcare conglomerate’s stock worth $66,044,000 after acquiring an additional 129,663 shares during the last quarter. Finally, Strata Wealth Advisors LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at $453,000. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of recent research reports. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Oppenheimer raised their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. TD Cowen increased their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Two research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Stock Up 2.9 %

Shares of UnitedHealth Group stock opened at $524.78 on Wednesday. The firm has a market cap of $482.95 billion, a price-to-earnings ratio of 33.86, a PEG ratio of 1.38 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a 50-day moving average of $547.07 and a 200 day moving average of $563.84.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the business posted $5.83 EPS. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.